Health management is rapidly moving away from the model of visiting a hospital only after symptoms appear and toward anticipating risks in advance based on data accumulated in daily life. Samsung Galaxy Watch’s heart health score and Handok’s sleep business strategy show attempts to tie indicators such as sleep, activity levels, and heart rate into a single management flow, reducing the gap between diagnosis and follow-up observation.
This trend is not limited to device makers and pharmaceutical companies but is also expanding through collaboration between insurers and medical technology firms. The business agreement between Philips Korea and HoneyNaps and insurers’ targeting of women’s life-cycle needs suggest that health management services are changing from an add-on for selling insurance coverage into a core tool for long-term customer relationships and risk management.
The health functional food and bio-materials markets are also moving beyond the stage of broadly promoting general benefits and into competition among products with more narrowly defined purposes, such as blood sugar, metabolism, skin, and hair loss. The expansion of products built around an individually approved red ginseng ingredient recognized for blood sugar control functionality and a technology commercialization briefing on beauty and health materials show that companies are beginning to place differentiated evidence and the securing of raw materials at the center of their business competitiveness.
However, market expansion does not automatically lead to greater trust. While some are strengthening human clinical evidence, as seen in a study of adults who consumed red ginseng extract for three weeks, many products still have inconsistent ingredient compositions and weak evidence of effectiveness, as shown in an analysis of 201 menopause supplements sold in the UK. Consumers are entering a phase in which they need to examine the level of research and safety information more carefully than the product name itself.
As public interest in health grows, the focus of regulation is shifting from expanding sales to controlling claims. Authorities detected 49,939 cases of improper online advertising for general foods, and repeated examples such as online advertising for albumin foods, which make ordinary foods appear to have treatment or improvement effects, have turned misleading promotional practices into a structural issue that distorts consumer judgment.
In particular, health products that spread through holiday gift demand or online recommendation algorithms may pose greater risks after consumption than at the moment of purchase. The results of an inspection of 300 food advertisements for Chuseok gift items and information on precautions when taking health functional foods together with medicine show that even if health foods are distributed like everyday consumer goods, issues such as drug interactions and false efficacy claims still need to be managed at the actual usage stage.
It is also becoming more noticeable that warnings surrounding individuals’ eating habits and consumption choices are leading to discussions on strengthening institutions and regulations. Research on dietary factors and the increase in colorectal cancer patients under age 50 is prompting debate over adjusting screening ages and methods, while a case in which an accident occurred during a lifting procedure performed under sleep sedation highlighted the need to separately review sedation safety standards in cosmetic medical settings.
Ultimately, the core of the recent trend is that while health-related choices have become more detailed and personalized, the risks are also becoming easier to shift onto individuals. The reason why concerns over possible liver injury related to ashwagandha extract are discussed alongside basic principles such as exercising two to three times a week and getting at least seven hours of sleep is that as new technologies and products continue to increase, the value of proven lifestyle habits and safety standards is growing even more.